EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 143 filers reported holding EPIZYME INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | -33.3% | 68 | -72.8% | 0.00% | – |
| Q3 2018 | $3,000 | -62.5% | 250 | -44.4% | 0.00% | – |
| Q2 2018 | $8,000 | 0.0% | 450 | 0.0% | 0.00% | – |
| Q1 2018 | $8,000 | +33.3% | 450 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | -45.5% | 450 | -19.9% | 0.00% | – |
| Q3 2017 | $11,000 | +450.0% | 562 | +401.8% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 112 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 112 | +2.8% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 109 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |